NCT01373983View on ClinicalTrials.gov

Intrathecal Bolus Doses of Ziconotide

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Peripheral Neuropathy
Interventions
DRUG

Ziconotide

1.25 or 2.5 mcg or 3.75 mcg i.t. according to an algorithm

Trial Locations (1)

SE-581 85

Pain and Rehabilitation Centre, University Hospital, Linköping

All Listed Sponsors
lead

University Hospital, Linkoeping

OTHER

NCT01373983 - Intrathecal Bolus Doses of Ziconotide | Biotech Hunter | Biotech Hunter